Live
FierceBiotechFosun pays $60M for option on AriBio’s phase 3 Alzheimer’s assetBioPharma DiveAssertio accepts new buyout bid; AI biotech Isomorphic banks $2BEndpoints NewsBehind Galapagos’ transformation into Lakefront BiotherapeuticsFierceBiotechValneva to lay off up to 15% of workforce in face of ‘adverse trend’ in travel vaccinesPharmaVoiceIndia’s pharma industry is going global. But can it catch up to China?PharmaVoiceWhy the FDA’s push for real-time clinical trials could favor Big PharmaLabiotechWhat investors now expect from AI biotech companiesBioWorldTracking hantavirus across the globeFierceBiotechMedtronic to shutter Santa Rosa plant as it restructures cardio vascular unitEndpoints NewsTessera reveals strongest data yet for in vivo sickle cell therapy10x Genomics BlogAnalysts Are Updating Their 10x Genomics, Inc. (NASDAQ:TXG) Estimates After Its First-Quarter Results - simplywall.stBioPharma Dive[Podcast] Closing the Distance in Cancer Care

Archive

Latest Oldest
Total 10972
Page 423 / 610
Query --